These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 25728500)

  • 41. Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias.
    de Matos Simoes R; Shirasaki R; Downey-Kopyscinski SL; Matthews GM; Barwick BG; Gupta VA; Dupéré-Richer D; Yamano S; Hu Y; Sheffer M; Dhimolea E; Dashevsky O; Gandolfi S; Ishiguro K; Meyers RM; Bryan JG; Dharia NV; Hengeveld PJ; Brüggenthies JB; Tang H; Aguirre AJ; Sievers QL; Ebert BL; Glassner BJ; Ott CJ; Bradner JE; Kwiatkowski NP; Auclair D; Levy J; Keats JJ; Groen RWJ; Gray NS; Culhane AC; McFarland JM; Dempster JM; Licht JD; Boise LH; Hahn WC; Vazquez F; Tsherniak A; Mitsiades CS
    Nat Cancer; 2023 May; 4(5):754-773. PubMed ID: 37237081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis.
    Tian R; Abarientos A; Hong J; Hashemi SH; Yan R; Dräger N; Leng K; Nalls MA; Singleton AB; Xu K; Faghri F; Kampmann M
    Nat Neurosci; 2021 Jul; 24(7):1020-1034. PubMed ID: 34031600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional genomics approaches to improve pre-clinical drug screening and biomarker discovery.
    Nguyen LV; Caldas C
    EMBO Mol Med; 2021 Sep; 13(9):e13189. PubMed ID: 34254730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic testing for exercise prescription and injury prevention: AIS-Athlome consortium-FIMS joint statement.
    Vlahovich N; Hughes DC; Griffiths LR; Wang G; Pitsiladis YP; Pigozzi F; Bachl N; Eynon N
    BMC Genomics; 2017 Nov; 18(Suppl 8):818. PubMed ID: 29143596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The promise of genetic screens in human
    Beirute-Herrera J; López-Amo Calvo B; Edenhofer F; Esk C
    Biol Chem; 2024 Jan; 405(1):13-24. PubMed ID: 37697643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-throughput screens in mammalian cells using the CRISPR-Cas9 system.
    Peng J; Zhou Y; Zhu S; Wei W
    FEBS J; 2015 Jun; 282(11):2089-96. PubMed ID: 25731961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-throughput functional genomics using CRISPR-Cas9.
    Shalem O; Sanjana NE; Zhang F
    Nat Rev Genet; 2015 May; 16(5):299-311. PubMed ID: 25854182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis.
    Chen S; Sanjana NE; Zheng K; Shalem O; Lee K; Shi X; Scott DA; Song J; Pan JQ; Weissleder R; Lee H; Zhang F; Sharp PA
    Cell; 2015 Mar; 160(6):1246-60. PubMed ID: 25748654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference.
    Barrangou R; Birmingham A; Wiemann S; Beijersbergen RL; Hornung V; Smith Av
    Nucleic Acids Res; 2015 Apr; 43(7):3407-19. PubMed ID: 25800748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CRISPR-Cas9 for medical genetic screens: applications and future perspectives.
    Xue HY; Ji LJ; Gao AM; Liu P; He JD; Lu XJ
    J Med Genet; 2016 Feb; 53(2):91-7. PubMed ID: 26673779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system.
    Xie K; Minkenberg B; Yang Y
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3570-5. PubMed ID: 25733849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining.
    Maruyama T; Dougan SK; Truttmann MC; Bilate AM; Ingram JR; Ploegh HL
    Nat Biotechnol; 2015 May; 33(5):538-42. PubMed ID: 25798939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
    Pellagatti A; Dolatshad H; Valletta S; Boultwood J
    Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells.
    Chu VT; Weber T; Wefers B; Wurst W; Sander S; Rajewsky K; Kühn R
    Nat Biotechnol; 2015 May; 33(5):543-8. PubMed ID: 25803306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expanding the Biologist's Toolkit with CRISPR-Cas9.
    Sternberg SH; Doudna JA
    Mol Cell; 2015 May; 58(4):568-74. PubMed ID: 26000842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks.
    Parnas O; Jovanovic M; Eisenhaure TM; Herbst RH; Dixit A; Ye CJ; Przybylski D; Platt RJ; Tirosh I; Sanjana NE; Shalem O; Satija R; Raychowdhury R; Mertins P; Carr SA; Zhang F; Hacohen N; Regev A
    Cell; 2015 Jul; 162(3):675-86. PubMed ID: 26189680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CRISPR multitargeter: a web tool to find common and unique CRISPR single guide RNA targets in a set of similar sequences.
    Prykhozhij SV; Rajan V; Gaston D; Berman JN
    PLoS One; 2015; 10(3):e0119372. PubMed ID: 25742428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.
    Kennedy EM; Cullen BR
    Virology; 2015 May; 479-480():213-20. PubMed ID: 25759096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Taylor J; Woodcock S
    J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers.
    Hilton IB; D'Ippolito AM; Vockley CM; Thakore PI; Crawford GE; Reddy TE; Gersbach CA
    Nat Biotechnol; 2015 May; 33(5):510-7. PubMed ID: 25849900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.